Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S. Grasso, Antoni Ribas, Mykola Onyshchenko et al.|Cancer Cell|2020Cited by 379
Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint BlockadeGabriel Abril-Rodríguez, Antoni Ribas|Cancer Research Communications|2022Cited by 18